Rosalind Advisors’s Geron GERN Stock Holding History

Rosalind Advisors’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-200,000	Closed	-$848K	–	36
2024 Q2	$848K	Hold	200,000	–	–	0.65%	27
2024 Q1	$660K	Hold	200,000	–	–	0.62%	29
2023 Q4	$422K	Buy	+200,000	New	+$389K	0.35%	29

Other funds holding GERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Rosalind Advisors's GERN Position: Q3 2024 in Review

Rosalind Advisors sold out of Geron (GERN) in Q3 2024, closing a stake of 200,000 shares — an estimated $848K sold.

Rosalind Advisors first reported a position in GERN in Q4 2023 and held it in 3 quarters. The position peaked at $848K in Q2 2024. 255 funds tracked by Wall St. Rank hold GERN as of Q3 2024.

Rosalind Advisors reported no remaining Geron position as of Q3 2024 after selling out during the quarter.
Rosalind Advisors sold 200,000 Geron shares in Q3 2024, an estimated $848K.
Rosalind Advisors first reported a position in Geron in Q4 2023 and held it in 3 quarters.
Rosalind Advisors's Geron position peaked at $848K in Q2 2024.
255 funds tracked by Wall St. Rank held Geron as of Q3 2024.

Based on Rosalind Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.